Q1 Report - Focused Execution Driving Growth

Biovica delivered 56% sales growth in the first quarter, driven by strong Pharma Services momentum, while taking decisive actions to streamline operations, strengthen leadership, and position the company for its next phase of growth. UPPSALA, SE / …